NCT01710072View on ClinicalTrials.gov

Aspirin Attenuates Inflammation in Human Cerebral Aneurysms

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
The Focus of the Study is to Monitor MRI Signal Changes and Inflammatory Biomarkers With Use of Aspirin in Patients With Unruptured Cerebral Aneurysm
Interventions
DRUG

aspirin

Trial Locations (1)

52242

University of Iowa hospitals and Clinics, Iowa City

All Listed Sponsors
lead

University of Iowa

OTHER

NCT01710072 - Aspirin Attenuates Inflammation in Human Cerebral Aneurysms | Biotech Hunter | Biotech Hunter